# Rznomics Inc. jobs and careers

> 0 open roles at Rznomics Inc. as of October 23, 2026. Source: https://www.thejobsmap.com/company/rznomics-inc

Rznomics is developing safe and effective biopharmaceuticals in oncology, degenerative disease, and genetic disease based on RNA platform technology called trans-splicing ribozyme. Acknowledged by bio-focused institutions, Rznomics has raised \23.7 billion from series A& B and recently raised \37.2 billion from series C, resulting in a total of \60.9 billion of fundraising. Also, Rznomics received \8 billion for the new drug development research funding from the government. In 2022 1H, Rznomics’ RZ-001 IND submission for the HCC treatment was approved by MFDS, and the clinical trial for the RZ-001 is currently running. In addition to the RZ-001, Rznomics has competitive and innovative pipelines, such as glioblastoma multiforme, Alzheimer’s disease, genetic ocular disease (retinitis pigmentosa), and circular RNA technology. Rznomics is also actively partnering with global companies to discuss collaboration opportunities in co-research, co-development, and licensing. Rznomics entered global licensing agreement with Eli Lilly for RNA-editing Therapeutics in May 2025, and was listed on KOSDAQ market in Dec 2025.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Founded | 2017 |
| Employees | 11 to 50 |
| Total funding | $59.7B |
| Industries | Biopharma, Biotechnology |
| Website | https://rznomics.com |

## Leadership

- Seong-Wook Lee, CEO & Founder

## Common questions

### Is Rznomics Inc. hiring right now?

Rznomics Inc. has no open roles listed as of October 23, 2026. Roles appear here as soon as they are posted on Rznomics Inc.'s careers site.

### Who leads Rznomics Inc.?

Seong-Wook Lee, CEO & Founder, is at the top of Rznomics Inc.'s org chart.

### How do I apply for a job at Rznomics Inc.?

Pick a role on Rznomics Inc.'s TheJobsMap page and select Apply. Every listing links to the original posting on Rznomics Inc.'s own careers site, so you apply directly with the employer.